Literature DB >> 16360385

Clinical outcomes of laparoscopic adrenalectomy for lateralizing nodular hyperplasia.

Yuri W Novitsky1, Kent W Kercher, Michael J Rosen, William S Cobb, Sathya Jyothinagaram, B Todd Heniford.   

Abstract

BACKGROUND: Nodular adrenal hyperplasia (NAH) may mimic the biochemical characteristics of an aldosterone-producing adenoma. The authors evaluated the outcomes of unilateral laparoscopic adrenalectomy in the setting of lateralizing aldosterone hypersecretion by NAH.
METHODS: Retrospective review of consecutive patients who underwent a laparoscopic adrenalectomy for primary hyperaldosteronism owing to NAH was performed. Patient demographics, perioperative symptoms, medications, radiographic findings, and serum chemistries were analyzed. Response to operation was classified according to postoperative control of hypertension and hypokalemia as resolved, improved, or refractory.
RESULTS: From January 1999 to October 2004, 15 patients underwent a laparoscopic unilateral adrenalectomy for hyperaldosteronism owing to lateralizing NAH. Nine (60%) patients presented with > or =5 years of hypertension, including 8 (53%) patients with labile or malignant hypertension. Ten (67%) patients had hypokalemia. Abdominal imaging results were normal in 9 (60%) patients. All patients underwent adrenal venous sampling (94% successfully), which revealed an average adjusted aldosterone ratio of 17.6 (range, 1.2 to 75.9). At a mean follow-up of 26 (range, 4 to 58) months, hypertension had resolved in 4 (27%), improved in 8 (53%), and was refractory in 3 (20%) patients. Hypokalemia resolved in all patients. There were no complications, conversions, or mortalities.
CONCLUSION: This series shows that unilateral adrenalectomy for lateralizing NAH results in eradication of hypokalemia and resolution or significant improvement in hypertension in 80% of patients at long-term follow-up. When lateralization of aldosterone production is noted, laparoscopic adrenalectomy provides significant clinical improvement even in patients with a pathologic diagnosis of NAH.

Entities:  

Mesh:

Year:  2005        PMID: 16360385     DOI: 10.1016/j.surg.2005.09.027

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  14 in total

1.  Walz aldosteronoma.

Authors:  Elizabeth G Grubbs; Jeffrey E Lee
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

2.  Noninvasive adrenal imaging in hyperaldosteronism: is it accurate for correctly identifying patients who should be selected for surgery?

Authors:  Celestino Pio Lombardi; Marco Raffaelli; Carmela De Crea; Vittoria Rufini; Giorgio Treglia; Rocco Bellantone
Journal:  Langenbecks Arch Surg       Date:  2007-01-23       Impact factor: 3.445

3.  Is adrenal venous sampling mandatory before surgical decision in case of primary hyperaldosteronism?

Authors:  Augustin Pirvu; Nora Naem; Jean Philippe Baguet; Frédéric Thony; Olivier Chabre; Philippe Chaffanjon
Journal:  World J Surg       Date:  2014-07       Impact factor: 3.352

4.  A retrospective study of laparoscopic unilateral adrenalectomy for primary hyperaldosteronism caused by unilateral adrenal hyperplasia.

Authors:  Shao-bo Jiang; Xu-dong Guo; Han-bo Wang; Ruo-zhen Gong; Hui Xiong; Zheng Wang; Hai-yang Zhang; Xun-bo Jin
Journal:  Int Urol Nephrol       Date:  2014-02-02       Impact factor: 2.370

Review 5.  Approach to the surgical management of primary aldosteronism.

Authors:  Maurizio Iacobone; Marilisa Citton; Giovanni Viel; Gian Paolo Rossi; Donato Nitti
Journal:  Gland Surg       Date:  2015-02

6.  Primary Aldosteronism: Does Underlying Pathology Impact Clinical Presentation and Outcomes Following Unilateral Adrenalectomy?

Authors:  Omair A Shariq; Kabir Mehta; Geoffrey B Thompson; Melanie L Lyden; David R Farley; Irina Bancos; Benzon M Dy; William F Young; Travis J McKenzie
Journal:  World J Surg       Date:  2019-10       Impact factor: 3.352

Review 7.  Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism.

Authors:  Laurence Amar; Pierre-François Plouin; Olivier Steichen
Journal:  Orphanet J Rare Dis       Date:  2010-05-19       Impact factor: 4.123

8.  The value of losartan suppression test in the confirmatory diagnosis of primary aldosteronism in patients over 50 years old.

Authors:  Chin-Chi Kuo; Poojitha Balakrishnan; Yenh-Chen Hsein; Vin-Cent Wu; Shih-Chieh Jeff Chueh; Yung-Ming Chen; Kwan-Dun Wu; Ming-Jiuh Wang
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2014-07-16       Impact factor: 1.636

9.  Long-term effects of surgical correction of adrenal hyperplasia and adenoma causing primary aldosteronism.

Authors:  J Hennings; S Andreasson; J Botling; A Hägg; A Sundin; P Hellman
Journal:  Langenbecks Arch Surg       Date:  2009-05-06       Impact factor: 3.445

10.  Functional imaging with 11C-metomidate PET for subtype diagnosis in primary aldosteronism.

Authors:  Minna Soinio; Anna-Kaarina Luukkonen; Marko Seppänen; Jukka Kemppainen; Janne Seppänen; Juha-Pekka Pienimäki; Helena Leijon; Tiina Vesterinen; Johanna Arola; Eila Lantto; Semi Helin; Ilkka Tikkanen; Saara Metso; Tuomas Mirtti; Ilkka Heiskanen; Leena Norvio; Mirja Tiikkainen; Tuula Tikkanen; Timo Sane; Matti Välimäki; Celso E Gomez-Sanchez; Ilkka Pörsti; Pirjo Nuutila; Pasi I Nevalainen; Niina Matikainen
Journal:  Eur J Endocrinol       Date:  2020-12       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.